HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Sumanta Pal Selected Research
Sumanta Pal Research Topics
Disease
36
Neoplasms (Cancer)
04/2024 - 09/2009
22
Renal Cell Carcinoma (Grawitz Tumor)
01/2023 - 10/2014
13
Prostatic Neoplasms (Prostate Cancer)
10/2023 - 02/2014
10
Carcinoma (Carcinomatosis)
04/2024 - 01/2016
4
Breast Neoplasms (Breast Cancer)
01/2017 - 09/2009
3
Neoplasm Metastasis (Metastasis)
11/2022 - 11/2011
3
Fatigue
01/2020 - 07/2016
3
Nausea
02/2019 - 07/2012
3
Disease Progression
01/2017 - 01/2016
2
Melanoma (Melanoma, Malignant)
12/2023 - 01/2022
2
Kidney Neoplasms (Kidney Cancer)
09/2023 - 12/2021
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 12/2017
2
Urinary Bladder Neoplasms (Bladder Cancer)
12/2021 - 01/2021
2
COVID-19
01/2021 - 01/2020
2
Hypertension (High Blood Pressure)
01/2020 - 07/2016
2
Adenocarcinoma
10/2019 - 01/2018
2
Hematologic Neoplasms (Hematological Malignancy)
01/2018 - 02/2013
1
Urogenital Neoplasms
12/2023
1
Hemorrhage
01/2023
1
Thrombosis (Thrombus)
01/2023
1
Venous Thromboembolism
01/2023
1
Lymphadenopathy
03/2022
1
Infections
01/2022
1
Renal Insufficiency (Renal Failure)
01/2020
1
Urologic Neoplasms (Urological Cancer)
10/2019
1
Dyspnea (Shortness of Breath)
10/2018
Drug/Important Bio-Agent (IBA)
10
cabozantinib
IBA
01/2023 - 07/2016
9
Everolimus
FDA Link
01/2023 - 03/2015
8
Immune Checkpoint Inhibitors
IBA
12/2023 - 01/2017
7
Biomarkers (Surrogate Marker)
IBA
04/2024 - 01/2017
5
DNA (Deoxyribonucleic Acid)
IBA
09/2023 - 01/2016
5
Platinum
IBA
01/2023 - 01/2017
4
atezolizumab
IBA
03/2022 - 01/2020
4
Cisplatin (Platino)
FDA Link
Generic
06/2021 - 01/2016
3
Androgens
IBA
01/2023 - 01/2020
3
Nivolumab
IBA
01/2022 - 01/2017
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2021 - 02/2019
2
pembrolizumab
IBA
01/2023 - 01/2022
2
Hormones (Hormone)
IBA
11/2022 - 03/2022
2
enzalutamide
IBA
03/2022 - 01/2022
2
abiraterone
IBA
03/2022 - 01/2022
2
Tyrosine Kinase Inhibitors
IBA
01/2022 - 07/2016
2
Ipilimumab
IBA
01/2022 - 01/2020
2
COVID-19 Vaccines
IBA
05/2021 - 01/2021
2
Cytokines
IBA
01/2021 - 01/2017
2
Axitinib (AG 013736)
IBA
01/2021 - 03/2015
2
Creatinine
IBA
01/2020 - 02/2019
2
Androgen Receptors (Androgen Receptor)
IBA
01/2020 - 02/2014
2
Phosphotransferases (Kinase)
IBA
06/2019 - 11/2011
2
MTOR Inhibitors
IBA
06/2019 - 01/2016
2
Sunitinib (Sutent)
FDA Link
02/2019 - 03/2015
2
Sorafenib (BAY 43-9006)
FDA Link
02/2019 - 03/2015
2
Estrogen Receptors
IBA
01/2017 - 09/2009
2
Oligonucleotides
IBA
01/2017 - 02/2013
2
Proteins (Proteins, Gene)
FDA Link
02/2014 - 02/2013
1
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
IBA
04/2024
1
infigratinib
IBA
04/2024
1
Mitogen-Activated Protein Kinases
IBA
10/2023
1
Serum Albumin
IBA
01/2023
1
Anticoagulants
IBA
01/2023
1
Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
IBA
01/2023
1
relugolix
IBA
01/2023
1
lenvatinib
IBA
01/2023
1
Gonadotropin-Releasing Hormone (GnRH)
FDA Link
11/2022
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2022
1
Steroids
IBA
01/2022
1
Circulating Tumor DNA
IBA
12/2021
1
Cell-Free Nucleic Acids
IBA
12/2021
1
Carboplatin (JM8)
FDA Link
Generic
06/2021
1
avelumab
IBA
06/2021
1
carotuximab
IBA
01/2021
1
sipuleucel-T (APC8015)
FDA Link
01/2021
1
Endoglin
IBA
01/2021
1
Monoclonal Antibodies
IBA
01/2021
1
Vaccines
IBA
01/2021
1
Cancer Vaccines
IBA
01/2021
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
01/2021
1
Fluorides
IBA
01/2020
1
Transforming Growth Factor beta (TGF-beta)
IBA
11/2019
1
Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)
IBA
11/2019
1
cyclopropapyrroloindole
IBA
11/2019
1
Sirolimus (Rapamycin)
FDA Link
06/2019
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
06/2019
1
trebananib
IBA
02/2019
1
Bevacizumab (Avastin)
FDA Link
02/2019
1
Angiopoietins
IBA
02/2019
1
pazopanib
FDA Link
02/2019
Therapy/Procedure
31
Therapeutics
04/2024 - 09/2009
12
Drug Therapy (Chemotherapy)
01/2023 - 09/2009
7
Immunotherapy
12/2023 - 12/2015
3
Radiotherapy
01/2023 - 11/2022
3
Castration
03/2022 - 01/2021
3
Prostatectomy (Retropubic Prostatectomy)
01/2022 - 01/2018
2
Cystectomy
12/2021 - 01/2016
2
Lymph Node Excision (Lymph Node Dissection)
09/2018 - 01/2018
2
Adjuvant Chemotherapy
07/2012 - 09/2009
1
Nephroureterectomy
04/2024
1
Nephrectomy
01/2023
1
Neoadjuvant Therapy
12/2021
1
Combination Drug Therapy (Combination Chemotherapy)
10/2019